Trastuzumab: Molecularly targeted therapy for early and metastatic HER-2/neu-positive breast cancer

Leisha A. Emens

Research output: Contribution to journalReview article

Fingerprint Dive into the research topics of 'Trastuzumab: Molecularly targeted therapy for early and metastatic HER-2/neu-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences